Dr. Krishna C. Alluri, MD

Dr. Alluri practices at Texas Oncology PA in San Antonio, Texas.

Dr. Alluri's NPI, 1992908347, was assigned on June 5, 2007. Dr. Alluri graduated from Gandhi Medical College in 2002. Dr. Alluri holds Texas license T6810.

Dr. Alluri's primary practice is Texas Oncology PA, at 2130 NE Loop 410, San Antonio, TX 78217 in Bexar County. The practice phone is (972) 997-8000.

Dr. Alluri's primary practice is Texas Oncology PA in San Antonio, Texas. Dr. Alluri is also affiliated with Methodist Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Alluri to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alluri practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Alluri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alluri is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Alluri's licenses on file in 6 states: Texas, Idaho, North Carolina, Florida, Tennessee and Massachusetts.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT) and lung cancer among the conditions Dr. Alluri treats.

CMS data shows 34,197 Medicare services from Dr. Alluri across 44 procedure codes in 2024, for 555 Medicare patients. Medicare paid $195,566 for them.

CMS counts 555 Medicare patients who saw Dr. Alluri in 2024. The largest group is 75 to 84, with 230 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alluri's median patient age at 68, with 67% women.

In 2024, Dr. Alluri wrote 761 Medicare Part D claims for 172 patients. 83% of them were for generic drugs. CMS names the drug for 611 of them, across 17 drugs with 11 or more claims each, at $1,158,280 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Alluri for performance year 2024, reported through an alternative payment model (APM). Dr. Alluri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alluri as offering telehealth.

Dmand AI links 30 papers to Dr. Alluri, published from 2013 to 2025. 2014 was the busiest year, with 6. The most frequent topics are Tomography, X-Ray Computed, Fluorodeoxyglucose F18 and Lung Neoplasms. Dr. Alluri has published most often in J Clin Oncol. Dr. Alluri's most frequent co-authors are Rathan M. Subramaniam, MD, MPH, PhD, Richard L. Wahl, MD and Lyudmila A. Bazhenova, MD.

Dmand AI links Dr. Alluri to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinosarcoma and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 16 general payments to Dr. Alluri from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Genmab U.S., Inc. paid the most, $125.

Dr. Alluri graduated from Gandhi Medical College in 2002.

Dr. Alluri is in network with 25 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.